Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effect of Omega-3 Fatty Acids Supplementation on Cardio-Metabolic and Oxidative Stress Parameters in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis Publisher Pubmed



Fazelian S1 ; Moradi F2 ; Agah S3 ; Hoseini A4 ; Heydari H5 ; Morvaridzadeh M6 ; Omidi A6 ; Pizarro AB7 ; Ghafouri A8 ; Heshmati J6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Clinical Research Development Unit, Ayatollah Kashani Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran
  2. 2. Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Education and Health Promotion, School of Health, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
  6. 6. Department of Nutritional Science, School of Nutritional Science and Food Technology, Kermanshah University of Medical Sciences, Farabi Hospital, Faculty of Nutrition Sciences and Food Technology, Postal Code: 6715847141, Isar Square, Kermanshah, Iran
  7. 7. Pontificia Universidad Javeriana, Bogota, Colombia
  8. 8. Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran

Source: BMC Nephrology Published:2021


Abstract

Background: Omega-3 fatty acids (FAs) have been suggested as a beneficial supplement in chronic kidney disease (CKD) patients, but the results of randomized clinical trials (RCTs) are controversial. We conducted a systematic review and meta-analysis to evaluate all the RCTs about the impact of omega-3 FAs supplementation on cardiometabolic outcomes and oxidative stress parameters in patients with CKD. Methods: We performed a systematic database search in PubMed/MEDLINE, EMBASE, Scopus, Web of Science, and Cochrane Central, up to May 2020. We included all placebo-controlled randomized trials that assessed the effect of omega-3 FAs supplementation on any cardiometabolic outcomes: blood pressure, total cholesterol (TC), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) or triglycerides (TG) and oxidative stress parameters. Data were pooled using DerSimonian–Laird’s random-effects model. Results: Finally, thirteen articles met the inclusion criteria for this review omega-3 FAs supplementation significantly decrease TC (SMD: -0.26; 95% CI: − 0.51, − 0.02; I2 = 52.7%), TG (SMD: -0.22; 95% CI: − 0.43, − 0.02; I2 = 36.0%) and Malondialdehyde (MDA) levels (SMD: -0.91; 95% CI: − 1.29, − 0.54; I2 = 00.0%) and also significantly increase superoxide dismutase (SOD) (SMD: 0.58; 95% CI: 0.27, 0.90; I2 = 00.0%) and Glutathione peroxidase (GPx) (SMD: 0.50; 95% CI: 0.14, 0.86; I2 = 00.0%) activities. However our results show that omega-3 FAs supplementation have no significant effects on HDL, LDL and blood pressure. Conclusion This systematic review and meta-analysis supports current evidence for the clinical benefit of omega-3 FAs intake to improve cardiometabolic parameters in CKD patients. However, well-designed RCTs still needed to provide a conclusive picture in this field. © 2021, The Author(s).
Experts (# of related papers)
Other Related Docs
22. The Association Between Non Soy Legume Consumption and Cardiovascular Risk Factors, Journal of Babol University of Medical Sciences (2015)
27. Effect of High Protein Diet on Cardiovascular Disease Risk Factors, Journal of Isfahan Medical School (2012)
35. Effects of Shrimp Oil on Cardio-Metabolic Risk Factors in Children and Adolescents, International Journal for Vitamin and Nutrition Research (2023)
41. Effect of Fatty Acids on Bone Health and Osteoporosis, Journal of Babol University of Medical Sciences (2013)